Spyre Therapeutics
SYRE
#2033
Rank
$9.92 B
Marketcap
$104.48
Share price
-4.15%
Change (1 day)
371.06%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Spyre Therapeutics CIK: 0001636282

Thumbnail Spyre Therapeutics 10-K Annual Report 2025

10-K Annual Report 2025

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2016

10-K Annual Report 2016

Language: English

View Annual Report (10-K)